one thing to worry about - insulin cross-reacts with the IGF receptor and insulin is a mild carcinogen; but insulin variants and insulin reformulations can be extremely potent carcinogens. Presumably they did IGF cross-reaction studies, but the post-digestive tract form might have different properties even, and before getting too excited, I'd want to wait for results from a longitudinal study in the clinic.